{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:24:08Z","timestamp":1780633448897,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04269-w","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T12:02:10Z","timestamp":1711627330000},"page":"3214-3219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic value of dual-time point 68Ga-PSMA PET\/CT image for benign and malignant lesions in patients with prostate cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Liu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"4269_CR1","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1007\/s00261-021-03071-2","volume":"46","author":"L Pang","year":"2021","unstructured":"Pang L, Bo X, Wang J, Wang C, Wang Y, Liu G, Yu H, Chen L, Shi H, Liu H (2021) Role of dual-time point (18)F-FDG PET\/CT imaging in the primary diagnosis and staging of hilar cholangiocarcinoma. Abdom Radiol (NY) 46:4138-4147. https:\/\/doi.org\/10.1007\/s00261-021-03071-2","journal-title":"Abdom Radiol (NY)"},{"key":"4269_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/rlu.0000000000004110","volume":"47","author":"SW Lee","year":"2022","unstructured":"Lee SW, Kim SJ(2022) Is delayed image of 18F-FDG PET\/CT necessary for mediastinal lymph node staging in Non-Small cell lung cancer patients? CLIN NUCL MED 47:414-421. https:\/\/doi.org\/10.1097\/rlu.0000000000004110","journal-title":"Clin Nucl Med"},{"key":"4269_CR3","doi-asserted-by":"publisher","first-page":"e32331","DOI":"10.1097\/md.0000000000032331","volume":"102","author":"L Yu","year":"2023","unstructured":"Yu L, Huang S, Wu S, Yue J, Yin L, Lin Z(2023) Comparison of 18F-FDG PET\/CT imaging with different dual time 18F-FDG PET\/CT with forced diuresis in clinical diagnosis of prostate cancer. Medicine (Baltimore) 102:e32331. https:\/\/doi.org\/10.1097\/md.0000000000032331","journal-title":"Medicine (Baltimore)"},{"key":"4269_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/rlu.0000000000004524","volume":"48","author":"RA Bundschuh","year":"2023","unstructured":"Bundschuh RA, Lutje S, Bundschuh L, Lapa C, Higuchi T, Hartrampf PE, Gorin MA, Kosmala A, Buck AK, Pomper MG, Rowe SP, Essler M, Sheikh GT, Werner RA(2023) High interobserver agreement on PSMA PET\/CT even in the absence of clinical data. CLIN NUCL MED 48:207-212. https:\/\/doi.org\/10.1097\/rlu.0000000000004524","journal-title":"Clin Nucl Med"},{"key":"4269_CR5","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1097\/rlu.0000000000004572","volume":"48","author":"S Riaz","year":"2023","unstructured":"Riaz S, Priftakis D, Afaq A, Kayani I, Bomanji J(2023) 68 Ga-PSMA-Avid Intranasal Solitary Fibrous Tumor. CLIN NUCL MED 48:e184-e185. https:\/\/doi.org\/10.1097\/rlu.0000000000004572","journal-title":"Clin Nucl Med"},{"key":"4269_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/rlu.0000000000004408","volume":"48","author":"A Moreau","year":"2023","unstructured":"Moreau A, Pretet V, Paquet E, Giraudet AL, Kryza D(2023) Intense diffuse lung uptake due to interstitial pneumopathy related to polyangiitis granulomata in 68 Ga-PSMA-11 PET\/CT. CLIN NUCL MED 48:261-263. https:\/\/doi.org\/10.1097\/rlu.0000000000004408","journal-title":"CLIN NUCL MED"},{"key":"4269_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00259-017-3669-5","volume":"44","author":"S Schmuck","year":"2017","unstructured":"Schmuck S, Nordlohne S, von Klot CA, Henkenberens C, Sohns JM, Christiansen H, Wester HJ, Ross TL, Bengel FM, Derlin T(2017) Comparison of standard and delayed imaging to improve the detection rate of [(68)Ga]PSMA I&T PET\/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer. Eur J Nucl Med Mol Imaging 44:960-968. https:\/\/doi.org\/10.1007\/s00259-017-3669-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4269_CR8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s11307-018-1263-2","volume":"21","author":"M Hohberg","year":"2019","unstructured":"Hohberg M, Kobe C, Tager P, Hammes J, Schmidt M, Dietlein F, Wild M, Heidenreich A, Drzezga A, Dietlein M(2019) Combined early and late [(68)Ga]PSMA-HBED-CC PET scans improve lesion detectability in biochemical recurrence of prostate cancer with low PSA levels. MOL IMAGING BIOL 21:558-566. https:\/\/doi.org\/10.1007\/s11307-018-1263-2","journal-title":"MOL IMAGING BIOL"},{"key":"4269_CR9","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1097\/rlu.0000000000002966","volume":"45","author":"J Kunikowska","year":"2020","unstructured":"Kunikowska J, Kujda S, Krolicki L(2020) 68Ga-PSMA PET\/CT in recurrence prostate cancer. Should we perform delayed image in cases of negative 60 minutes postinjection examination? CLIN NUCL MED 45:e213-e214. https:\/\/doi.org\/10.1097\/rlu.0000000000002966","journal-title":"CLIN NUCL MED"},{"key":"4269_CR10","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1097\/rlu.0000000000003440","volume":"46","author":"S Santhosh","year":"2021","unstructured":"Santhosh S, Jeeva G(2021) Delayed 68Ga-PSMA PET\/CT Image-Guided biopsy for Low-Grade adenocarcinoma in benign prostatic hyperplasia. CLIN NUCL MED 46:e190-e192. https:\/\/doi.org\/10.1097\/rlu.0000000000003440","journal-title":"CLIN NUCL MED"},{"key":"4269_CR11","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.3390\/jcm11123311","volume":"11","author":"J Kunikowska","year":"2022","unstructured":"Kunikowska J, Pelka K, Tayara O, Krolicki L(2022) Ga-68-PSMA-11 PET\/CT in patients with biochemical recurrence of prostate cancer after primary treatment with curative Intent-Impact of delayed imaging. J CLIN MED 11:3311. https:\/\/doi.org\/10.3390\/jcm11123311","journal-title":"J CLIN MED"},{"key":"4269_CR12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2967\/jnumed.116.183483","volume":"58","author":"A Afshar-Oromieh","year":"2017","unstructured":"Afshar-Oromieh A, Sattler LP, Mier W, Hadaschik BA, Debus J, Holland-Letz T, Kopka K, Haberkorn U(2017) The clinical impact of additional late PET\/CT imaging with (68)Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer. J NUCL MED 58:750-755. https:\/\/doi.org\/10.2967\/jnumed.116.183483","journal-title":"J NUCL MED"},{"key":"4269_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00259-019-04548-5","volume":"47","author":"F Haupt","year":"2020","unstructured":"Haupt F, Dijkstra L, Alberts I, Sachpekidis C, Fech V, Boxler S, Gross T, Holland-Letz T, Zacho HD, Haberkorn U, Rahbar K, Rominger A, Afshar-Oromieh A(2020) (68)Ga-PSMA-11 PET\/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol. Eur J Nucl Med Mol Imaging 47:624-631. https:\/\/doi.org\/10.1007\/s00259-019-04548-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4269_CR14","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.3390\/cancers12102788","volume":"12","author":"MA Hoffmann","year":"2020","unstructured":"Hoffmann MA, Buchholz HG, Wieler HJ, Rosar F, Miederer M, Fischer N, Schreckenberger M(2020) Dual-Time point [(68)Ga]Ga-PSMA-11 PET\/CT hybrid imaging for staging and restaging of prostate cancer. Cancers (Basel) 12:2788. https:\/\/doi.org\/10.3390\/cancers12102788","journal-title":"Cancers (Basel)"},{"key":"4269_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.2967\/jnumed.122.265252","volume":"64","author":"C Berliner","year":"2023","unstructured":"Berliner C, Steinhelfer L, Chantadisai M, Kroenke M, Koehler D, Pose R, Bannas P, Knipper S, Eiber M, Maurer T(2023) Delayed imaging improves lesion detectability in [(99m)Tc]Tc-PSMA-I&s SPECT\/CT in recurrent prostate cancer. J NUCL MED 64:1036-1042. https:\/\/doi.org\/10.2967\/jnumed.122.265252","journal-title":"J NUCL MED"},{"key":"4269_CR16","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.2967\/jnumed.119.238071","volume":"61","author":"M Beheshti","year":"2020","unstructured":"Beheshti M, Manafi-Farid R, Geinitz H, Vali R, Loidl W, Mottaghy FM, Langsteger W: Multiphasic (68)Ga-PSMA PET\/CT in the detection of early recurrence in prostate cancer patients with a PSA level of less than 1 ng\/mL(2020) A prospective study of 135 patients. J NUCL MED 61:1484-1490. https:\/\/doi.org\/10.2967\/jnumed.119.238071","journal-title":"J NUCL MED"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04269-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04269-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04269-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T14:51:35Z","timestamp":1724338295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04269-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["4269"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04269-w","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"23 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}